Media Statements

Emergent BioSolutions launched a new television and digital ad as part of its “We Go” campaign

Today, Emergent BioSolutions launched a new television and digital ad as part of its “We Go” campaign that launched last May, sharing the company’s commitment to fighting the COVID-19 pandemic....

Emergent BioSolutions Statement on Status of Current Manufacturing of COVID-19 Vaccines at Company’s Baltimore Bayview Facility

GAITHERSBURG, Md., April 01, 2021 – At Emergent (NYSE: EBS), safety and quality are our top priorities. Our Bayview facility has been designed and validated to meet all current Good Manufacturing...

Emergent BioSolutions Statement on Johnson & Johnson’s Collaboration with Merck

GAITHERSBURG, Md. March 03, 2021 – Emergent BioSolutions welcomes the addition of Merck & Co’s capabilities to the fight against COVID-19, a move that will add to existing supply and help...

This website uses cookies. This site uses cookies to provide you with a more responsive and personalized service. By using this site you agree to the Privacy Notice and Terms of Use.